Loss or low activity of NQO1, by the reduction of its mRNA or the emergence of inactivating polymorphisms in the NQO1 gene, leads to resistance to 17-AAG in pancreatic cancer cells and glioblastoma cell lines [30, 21]. This evidence concerns the gene NQO1 and familial pancreatic carcinoma.